GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Update

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 104,500 shares, an increase of 217.6% from the January 31st total of 32,900 shares. Currently, 1.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,380,000 shares, the days-to-cover ratio is presently 0.0 days.

GlucoTrack Trading Up 4.5 %

GCTK stock traded up $0.02 during mid-day trading on Friday, hitting $0.37. The stock had a trading volume of 332,704 shares, compared to its average volume of 5,645,899. GlucoTrack has a 52 week low of $0.33 and a 52 week high of $99.00. The firm has a market capitalization of $3.86 million, a P/E ratio of -0.01 and a beta of -0.38. The firm has a fifty day simple moving average of $2.36 and a 200 day simple moving average of $22.50.

Institutional Investors Weigh In On GlucoTrack

A hedge fund recently raised its stake in GlucoTrack stock. Geode Capital Management LLC grew its stake in GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 112,787 shares of the company’s stock after purchasing an additional 85,626 shares during the period. Geode Capital Management LLC owned about 14.10% of GlucoTrack worth $42,000 as of its most recent filing with the Securities and Exchange Commission. 10.92% of the stock is currently owned by institutional investors.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.